Novavax Inc. (NVAX) Volume
Healthcare
Market data as of 2026-09-04 · Autonium metric computed 2026-09-04 · model v1NVAX volume — the short answer
NVAX's latest session volume was 5,123,200 against a 20-day average of 5,204,655, a Normal volume regime.
Volume
Latest session volume5,123,200
20-day average volume5,204,655
Ratio to average0.98x
Volume regimeNormal
Trend classificationUptrend
Signal drivers
MomentumPositive
Technical trendPositive
VolatilityNeutral
SentimentNeutral
NVAX's Algo Score fell 3 points over the last seven days. The factors currently reading positive are momentum, technical trend; reading negative: none.
Sector peers — 3-month return
LLY — Eli Lilly and Co.1.6
UNH — UnitedHealth Group-0.6
JNJ — Johnson & Johnson18.2
ABBV — AbbVie Inc.12.9
MRK — Merck & Co.24.5
Score history
- 2026-09-0785
- 2026-09-0485
- 2026-09-0385
- 2026-09-0286
- 2026-09-0193
- 2026-08-3188
- 2026-08-2881
- 2026-08-2779
- 2026-08-2679
- 2026-08-2581
- 2026-08-2469
- 2026-08-2180
Track NVAX inside Autonium
Full factor detail, alerts when the score changes, and Toni to ask why.
Continue analysing NVAX
Autonium publishes research, not recommendations. Scores, factors and written reads describe historical and current data and are not buy or sell advice. Not financial advice. Market data is refreshed on a schedule and may lag. See our methodology and disclosures.